1-866-647-3279

Psychedelics Services

Here's What You Need To Know

With an evolving regulatory landscape and increasing investment into the market, psychedelics, as a subject for research and clinical trials, is primed to be a major emerging industry in Canada. Companies looking to enter this burgeoning psychedelics market can count on dicentra Cannabis & Psychedelics Consulting to help them navigate the regulatory landscape for controlled substances related to psilocybin.

Our Services Include Consulting Support With The Following:

  • Filing for an exemption under Section 56(1) of the Controlled Drugs and Substances Act for physicians and researchers
  • Filing an application for a Controlled Drugs and Substances Dealer’s Licence
  • Obtaining a permit for both import and export of Controlled Substances from Health Canada
  • Obtaining an authorization to purchase a restricted drug from a licenced dealer for clinical trials
  • Obtaining an authorization for the sale of a restricted drug by a licenced dealer

    SPEAK WITH OUR EXPERTS NOW

    We will respond within one business day.

    Note: we do not share your email address with outside parties. You may unsubscribe at any time.

    Links
    Please Note

    dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in jurisdictions where cannabis is legal (whether for medical use or recreational use or both) on a federal level. We do not provide any consulting services whatsoever for cannabis-related business conducted in the United States of America, or in any of its States or Territories.

    Subscribe

    Stay abreast of regulatory updates, news, events, offers and more

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions